Synthon's Generic Copaxone 20mg Approved in Europe Today - Analyst (TEVA)
Tweet Send to a Friend
Evercore ISI analyst Umer Raffat notes that Synthon's generic of Teva Pharma (NYSE: TEVA) Copaxone 20 mg was approved today ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE